Skip to search formSkip to main contentSkip to account menu

Superficial Bladder Carcinoma

Known as: Superficial Bladder Cancer, Superficial Urinary Bladder Cancer, Superficial Urinary Bladder Carcinoma 
A term used by urologists to describe an infiltrating carcinoma of the bladder that has not invaded into the muscularis propria of the bladder wall… 
National Institutes of Health

Related topics

Related topics

8 relations
Epithelial CellsEpitheliumHematuriaMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
Highly Cited
2005
Highly Cited
2005
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
PURPOSE This study was an evaluation of whether restaging transurethral resection (TUR) of superficial bladder cancer improves… 
Highly Cited
2004
Highly Cited
2004
Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
Review
2003
Review
2003
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
PURPOSE Of all medical disciplines it is exclusively in urology in which immunotherapy for cancer has an established position… 
Highly Cited
2003
Highly Cited
2003
Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.
PURPOSE We examined the sensitivity and specificity of Hexvix (PhotoCure ASA, Oslo, Norway) hexyl aminolevulinate (HAL… 
Highly Cited
2003
Highly Cited
2003
Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
PURPOSE We determined the long-term outcome in patients with superficial bladder cancer (Ta and T1) undergoing routine second… 
Review
1997
Review
1997
The treated natural history of high risk superficial bladder cancer: 15-year outcome.
PURPOSE The long-term outcome of patients with high risk superficial bladder cancer is unknown. We report the results of 15 years… 
Highly Cited
1995
Highly Cited
1995
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
PURPOSE Superficial bladder tumors (stage Ta, T1, and Tis) may progress to invade the bladder muscle and cause death from… 
Highly Cited
1988
Highly Cited
1988
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
The effectiveness of BCG in preventing disease progression in patients with superficial bladder cancer is evaluated. Long-term… 
Highly Cited
1982
Highly Cited
1982
Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)